patienc requir still solid long-
buckle-in short-term prepar lt growth
result outlook show on-going stabil revenu
base also headwind cost fluctuat compani face
lack earli color like bit disappoint although also
think somewhat prudent move given delta last two year
initi color call formal guidanc call compani return
sustain margin pathway investor sentiment remain somewhat lumpi
ultim still see healthi pathway toward long-term growth driven
va/dod contract supplement increas work contract well
popul health busi given litani long-term growth driver see
attract risk/reward although fulli recogn short-term volatil could
creat margin expans think still long-term potenti
compani take rigor approach toward busi optim think
though execut cost opportun crucial long-term thesi
reiter buy rate reduc price object
lower ep estim higher cost base
follow result decreas ep
ep primarili driven lower oper margin includ
increas servic cost associ compani consult work project
well increment invest across busi also lower price
object repres ep ex-cash multipl unchang
upcom event catalyst
new revwork itwork deal could also serv posit catalyst addit
look new task order depart defens veteran affair
contract could drive increment comfort book perform final
color compani formul guidanc key toward understand
margin progress drive sentiment
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
largest stand-alone healthcar
compani sell wide rang softwar
servic hospit physician
product cerner millennium platform
serv base broader solut
offer also sell number addit
servic offer leverag clinic
infrastructur larg instal base
compani base kansa citi
buy rate base market leader
widest rang increment cross-sel
opportun within ever-grow custom
base compani also abl leverag
recent expens provid
increment cash flow appli
valuat overal market growth
slow vs post-american recoveri
reinvest act period see
continu share-gain becom
bifurc competit market
book y/i
margin weak driven lower softwar current quarter impact futur
histor provid preliminari outlook call
past two year updat outlook call
provid outlook year
implement four addit site
va sign contract three task order sign
initi site go live
outsid unit state
revenu growth driven uk sweden middl east canada
valu driven solut carri sens urgenc
believ revenu cycl itwork popul health continu
contribut growth
creat oper model abil scale
confirm margin expans still focu
look consensu one appli oper margin get
number that margin expans
cern purview
expect continu expand margin
continu non-gaap expens
smaller replac opportun happen year suggest
replac smaller
replac market noth chang
see activ replac market
competitor struggl see rfp activ relat
see consist level rfp
think capit alloc next year
consist said
share buyback off-set dilut
bleed softwar weak long drag
issu lower softwar sale
va contribut revenu base task order seem could
book flow revenu
primarili percent complet lot servic orient
lot flow work get done
long term short term
expect time-frame could task order drive
revenu wont necessarili linear
updat lumeri sens pmpm
area value-bas care think huge opportun
actual financi impact fairli limit earli
year time-frame anyth meaning contribut
softwar book quarter soft
typic lumpi
wasnt lack desir cern pipelin show lot interest
book outlook last year said number itwork last
healtheint progress sell outsid core millennium base
larg prioriti get outsid millennium base
price object base ep estim ex-cash multipl
five-year averag absolut multipl basi well rel
incorpor modest growth slowdown also premium
downsid risk po market paus spend particularli driven
healthcar reform uncertainti increas competit pressur epic system
well newer cloud-bas entiti integr cost associ va
dod contract hamper margin upsid risk would come acceler
cross-sel opportun notabl around popul health revenu upsid va
contract roll-out increas leverag drive improv margin expans potenti
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
